4 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow CBL-514: new trials by email Literature Review of CBL-514 trials Research Report on CBL-514
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 10 | 2022-02-11 | 2026-05-22 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 25 | 2020-12-09 | 2024-08-09 |
| A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat CBL-514 - Subcutaneous Fat | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 43 | 2020-02-03 | 2021-01-08 |
| A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers CBL-514, placebo, CBL-514 - Subcutaneous Fat | Phase 1 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 40 | 2018-11-27 | 2021-01-07 |
Caliway Biopharmaceuticals Co., Ltd. (4)
Australia (3) · United States (1)
Anne Sheu (1)